Security key
33733E203
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT)
CUSIP: 33733E203
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
- Shares outstanding
- 11,300,576
- Total 13F shares
- 3,418,857
- Share change
- +253,718
- Total reported value
- $568,580,158
- Price per share
- $166.21
- Number of holders
- 253
- Value change
- +$41,645,148
- Number of buys
- 100
- Number of sells
- 106
Report period
Q4 2024
Institutions
253
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 33733E203
Recent filing periods:
Top shareholders of FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q4 2024
As of 31 Dec 2024,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
253 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,418,857 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, LPL Financial LLC, RAYMOND JAMES FINANCIAL INC, Berger Financial Group, Inc, Royal Bank of Canada, ENVESTNET ASSET MANAGEMENT INC, and Csenge Advisory Group.
This page lists
253
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
252
Q4 2024 holders
253
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.